The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
The epidemiology of glioma in adults: a "state of the science" review
Open accessAbstract
Gliomas are the most common primary intracranial tumor, representing 81% of malignant brain tumors. Although relatively rare, they cause significant mortality and morbidity. Glioblastoma, the most common glioma histology (∼45% of all gliomas), has a 5-year relative survival of ∼5%. A small portion of these tumors are caused by Mendelian disorders, including neurofibromatosis, tuberous sclerosis, and Li-Fraumeni syndrome. Genomic analyses of glioma have also produced new evidence about risk and prognosis. Recently discovered biomarkers that indicate improved survival include O⁶-methylguanine-DNA methyltransferase methylation, isocitrate dehydrogenase mutation, and a glioma cytosine-phosphate-guanine island methylator phenotype. Genome-wide association studies have identified heritable risk alleles within 7 genes that are associated with increased risk of glioma. Many risk factors have been examined as potential contributors to glioma risk. Most significantly, these include an increase in risk by exposure to ionizing radiation and a decrease in risk by history of allergies or atopic disease(s). The potential influence of occupational exposures and cellular phones has also been examined, with inconclusive results. We provide a “state of the science” review of current research into causes and risk factors for gliomas in adults.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Radiotherapy Plus Concomitant and Adjuvant Temozolomide for Glioblastoma
Stupp, R., Mason, W. P., van den Bent, M. J., Weller, M., Fisher, B., Taphoorn, M. J. B., Belanger, K., Brandes, A. A., Marosi, C., Bogdahn, U., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043330 · Cited by 21,807
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The Cancer Genome Atlas Research Network (2008) · Nature · doi:10.1038/nature07385 · Cited by 7,735
Verhaak, R. G. W., Hoadley, K. A., Purdom, E., Wang, V., Qi, Y., Wilkerson, M. D., Miller, C. R., Ding, L., Golub, T., Mesirov, J. P., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2009.12.020 · Cited by 7,575
An Integrated Genomic Analysis of Human Glioblastoma Multiforme
Parsons, D. W., Jones, S., Zhang, X., Lin, J. C.-H., Leary, R. J., Angenendt, P., Mankoo, P., Carter, H., Siu, I.-M., Gallia, G. L., et al. (2008) · Science · doi:10.1126/science.1164382 · Cited by 5,857
IDH1 and IDH2 Mutations in Gliomas
Yan, H., Parsons, D. W., Jin, G., McLendon, R., Rasheed, B. A., Yuan, W., Kos, I., Batinic-Haberle, I., Jones, S., Riggins, G. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808710 · Cited by 5,847
The Somatic Genomic Landscape of Glioblastoma
Brennan, C. W., Verhaak, R. G. W., McKenna, A., Campos, B., Noushmehr, H., Salama, S. R., Zheng, S., Chakravarty, D., Sanborn, J. Z., Berman, S. H., et al. (2013) · Cell · doi:10.1016/j.cell.2013.09.034 · Cited by 5,016
Self-citationMathews, J. D., Forsythe, A. V., Brady, Z., Butler, M. W., Goergen, S. K., Byrnes, G. B., Giles, G. G., Wallace, A. B., Anderson, P. R., Guiver, T. A., et al. (2013) · BMJ · doi:10.1136/bmj.f2360 · Cited by 2,029
Research works printed but not linked: 146
- 2013, Neuro-Oncology, 15, ii1, 10.1093/neuonc/not151 · DOI · Paper page
- Louis, 2007, Acta neuropathologica, 114, 97, 10.1007/s00401-007-0243-4 · DOI · Paper page
- 2012, Asian Pacific journal of cancer prevention : APJCP, 13, 5857, 10.7314/APJCP.2012.13.11.5857 · DOI
- 2009, Neuro-Oncology, 11, 403, 10.1215/15228517-2008-097 · DOI
- Crocetti, 2012, European journal of cancer (Oxford, England : 1990), 48, 1532, 10.1016/j.ejca.2011.12.013 · DOI · Paper page
- Lee, 2010, 48, 145, 10.3340/jkns.2010.48.2.145 · DOI
- Deltour, 2012, Epidemiology (Cambridge, Mass.), 23, 301, 10.1097/EDE.0b013e3182448295 · DOI · Paper page
- Dobes, 2011, 2, 176, 10.4103/2152-7806.90696 · DOI
- Wohrer, 2009, Journal of neuro-oncology, 95, 401, 10.1007/s11060-009-9938-9 · DOI
- 2013, Journal of neuro-oncology, 112, 241, 10.1007/s11060-013-1054-1 · DOI
- 2007, Neuro-Oncology, 9, 319, 10.1215/15228517-2007-016 · DOI · Paper page
- Gousias, 2009, Neuroepidemiology, 33, 89, 10.1159/000222090 · DOI
- Dubrow, 2011, BMC cancer [electronic resource], 11, 325, 10.1186/1471-2407-11-325 · DOI
- 2009, Neuro-Oncology, 11, 311, 10.1215/15228517-2008-105 · DOI
- 2012, BMJ, 344, e1147, 10.1136/bmj.e1147 · DOI · Paper page
- Chitnavis, 2001, Journal of neurosurgery, 95, 190, 10.3171/jns.2001.95.2.0190 · DOI · Paper page
- 2010, Neuro-Oncology, 12, 725, 10.1093/neuonc/noq030 · DOI
- Sant, 2012, International journal of cancer. Journal international du cancer, 131, 173, 10.1002/ijc.26335 · DOI
- Tseng, 2006, Journal of neurosurgery, 105, 297
- Jung, 2012, Journal of neuro-oncology, 109, 301, 10.1007/s11060-012-0893-5 · DOI
- Jakola, 2012, JAMA, 308, 1881, 10.1001/jama.2012.12807 · DOI · Paper page
- Stupp, 2007, Journal of Clinical Oncology, 25, 4127, 10.1200/JCO.2007.11.8554 · DOI
- Koshy, 2012, Journal of neuro-oncology, 107, 207, 10.1007/s11060-011-0738-7 · DOI · Paper page
- 2012, Cancer, 118, 2163, 10.1002/cncr.26494 · DOI
- 2012, Cancer, 118, 5608, 10.1002/cncr.27590 · DOI
- Ohgaki, 2007, American Journal Of Pathology, 170, 1445, 10.2353/ajpath.2007.070011 · DOI · Paper page
- Noushmehr, 2010, Cancer cell, 17, 510, 10.1016/j.ccr.2010.03.017 · DOI · Paper page
- Jiao, 2012, 3, 709, 10.18632/oncotarget.588 · DOI · Paper page
- Smith, 2000, Journal of Clinical Oncology, 18, 636, 10.1200/JCO.2000.18.3.636 · DOI · Paper page
- 2010, OGPL Neurology, 74, 1886, 10.1212/WNL.0b013e3181e1cf3a · DOI · Paper page
- 2011, Science, 333, 1453, 10.1126/science.1210557 · DOI · Paper page
- Liu, 2012, Acta neuropathologica, 124, 615, 10.1007/s00401-012-1031-3 · DOI · Paper page
- Kannan, 2012, 3, 1194, 10.18632/oncotarget.689 · DOI · Paper page
- Hartmann, 2010, Acta neuropathologica, 120, 707, 10.1007/s00401-010-0781-z · DOI · Paper page
- 2013, Acta neuropathologica, 126, 277, 10.1007/s00401-013-1130-9 · DOI
- 2009, Journal of Clinical Oncology, 27, 5874, 10.1200/JCO.2009.23.6497 · DOI · Paper page
- Esteller, 2000, New England Journal of Medicine, 343, 1350, 10.1056/NEJM200011093431901 · DOI · Paper page
- Hegi, 2005, New England Journal of Medicine, 352, 997, 10.1056/NEJMoa043331 · DOI · Paper page
- 2013, Archives of medical research, 44, 281, 10.1016/j.arcmed.2013.04.004 · DOI
- Sadones, 2009, European journal of cancer (Oxford, England : 1990), 45, 146, 10.1016/j.ejca.2008.09.002 · DOI
- 2011, Clinical Cancer Research, 17, 7148, 10.1158/1078-0432.CCR-11-1274 · DOI
- 2013, PNAS, 110, 6021, 10.1073/pnas.1303607110 · DOI · Paper page
- 2013, Acta neuropathologica, 126, 267, 10.1007/s00401-013-1141-6 · DOI · Paper page
- 2013, Acta neuropathologica, 126, 443, 10.1007/s00401-013-1156-z · DOI · Paper page
- 2011, Cancer Research, 71, 7568, 10.1158/0008-5472.CAN-11-0013 · DOI
- 2012, Cancer Epidemiology Biomarkers & Prevention, 21, 2242, 10.1158/1055-9965.EPI-12-0703 · DOI
- 2012, Cancer genetics and cytogenetics, 205, 613, 10.1016/j.cancergen.2012.10.009 · DOI · Paper page
- de Andrade, 2001, Genetic epidemiology, 20, 258, 10.1002/1098-2272(200102)20:2<258::AID-GEPI8>3.0.CO;2-N · DOI
- Felini, 2007, Neuroepidemiology, 29, 55, 10.1159/000108919 · DOI
- 2007, Carcinogenesis, 28, 1906, 10.1093/carcin/bgm073 · DOI
- Bethke, 2008, Cancer Epidemiology Biomarkers & Prevention, 17, 1195, 10.1158/1055-9965.EPI-07-2733 · DOI
- 2013, Genetic epidemiology, 37, 222, 10.1002/gepi.21707 · DOI
- Wrensch, 2009, Nature genetics, 41, 905, 10.1038/ng.408 · DOI · Paper page
- Shete, 2009, Nature genetics, 41, 899, 10.1038/ng.407 · DOI · Paper page
- 2011, Human Molecular Genetics, 20, 2897, 10.1093/hmg/ddr192 · DOI
- Stacey, 2011, Nature genetics, 43, 1098, 10.1038/ng.926 · DOI · Paper page
- Rajaraman, 2012, Human genetics, 131, 1877, 10.1007/s00439-012-1212-0 · DOI
- Jenkins, 2011, 204, 13, 10.1016/j.cancergencyto.2010.10.002 · DOI
- 2013, Neuro-Oncology, 15, 542, 10.1093/neuonc/nos284 · DOI
- Jenkins, 2012, Nature genetics, 44, 1122, 10.1038/ng.2388 · DOI
- 2013, Human Molecular Genetics, 22, 2293, 10.1093/hmg/ddt063 · DOI
- 2013, Neuro-Oncology, 15, 535, 10.1093/neuonc/nos324 · DOI
- 2013, British Journal of Cancer, 108, 2178, 10.1038/bjc.2013.155 · DOI
- 2012, Journal of Medical Genetics, 49, 420, 10.1136/jmedgenet-2012-100941 · DOI
- 2011, American Journal of Epidemiology, 173, 915, 10.1093/aje/kwq457 · DOI
- 2012, JNCI Journal of the National Cancer Institute, 104, 840, 10.1093/jnci/djs222 · DOI
- 2013, Neuro-Oncology, 15, 1041, 10.1093/neuonc/not051 · DOI
- Berg-Beckhoff, 2009, European journal of epidemiology, 24, 433, 10.1007/s10654-009-9355-6 · DOI
- 2009, Cancer Epidemiology Biomarkers & Prevention, 18, 1232, 10.1158/1055-9965.EPI-08-0995 · DOI
- McCarthy, 2011, Cancer Epidemiology Biomarkers & Prevention, 20, 370, 10.1158/1055-9965.EPI-10-0948 · DOI
- Scheurer, 2008, Cancer Epidemiology Biomarkers & Prevention, 17, 1277, 10.1158/1055-9965.EPI-07-2621 · DOI
- Schoemaker, 2006, International journal of cancer. Journal international du cancer, 119, 2165, 10.1002/ijc.22091 · DOI
- 2013, Cancer causes & control : CCC, 24, 949, 10.1007/s10552-013-0171-7 · DOI
- Wiemels, 2009, International journal of cancer. Journal international du cancer, 125, 680, 10.1002/ijc.24369 · DOI
- 2007, American Journal of Epidemiology, 166, 941, 10.1093/aje/kwm203 · DOI
- 2007, JNCI Journal of the National Cancer Institute, 99, 1544, 10.1093/jnci/djm170 · DOI · Paper page
- 2011, Neuro-Oncology, 13, 242, 10.1093/neuonc/noq173 · DOI
- 2013, Cancer Epidemiology Biomarkers & Prevention, 37, 908
- Scheurer, 2011, International journal of cancer. Journal international du cancer, 129, 2290, 10.1002/ijc.25883 · DOI
- Wiemels, 2007, Cancer Epidemiology Biomarkers & Prevention, 16, 1229, 10.1158/1055-9965.EPI-07-0041 · DOI
- 2011, JNCI Journal of the National Cancer Institute, 103, 1588, 10.1093/jnci/djr361 · DOI
- Schlehofer, 2011, Allergy, 66, 1434, 10.1111/j.1398-9995.2011.02670.x · DOI
- 2012, JNCI Journal of the National Cancer Institute, 104, 1251, 10.1093/jnci/djs315 · DOI
- 2010, Neuro-Oncology, 12, 444, 10.1093/neuonc/nop057 · DOI
- 2013, Journal of neuro-oncology, 113, 229, 10.1007/s11060-013-1122-6 · DOI
- 2007, Carcinogenesis, 28, 2543, 10.1093/carcin/bgm210 · DOI
- 2011, Frontiers in bioscience : a journal and virtual library, 3, 33, 10.2741/e217 · DOI
- 2013, Cancer Epidemiology Biomarkers & Prevention, 37, 306
- 2011, American Journal of Epidemiology, 174, 574, 10.1093/aje/kwr124 · DOI
- 2014, International journal of cancer. Journal international du cancer, 134, 2199, 10.1002/ijc.28535 · DOI
- 2010, Carcinogenesis, 31, 1770, 10.1093/carcin/bgq152 · DOI
- Turner, 2012, Cancer immunology, immunotherapy : CII, 61, 1493, 10.1007/s00262-011-1180-6 · DOI
- 2010, Neuro-Oncology, 12, 320, 10.1093/neuonc/nop035 · DOI
- Komohara, 2012, Cancer Science, 103, 2165, 10.1111/cas.12015 · DOI
- Bondy, 2008, Cancer, 113, 1953, 10.1002/cncr.23741 · DOI · Paper page
- Sadetzki, 2005, Radiation research, 163, 424, 10.1667/RR3329 · DOI
- Preston, 2007, Radiation research, 168, 1, 10.1667/RR0763.1 · DOI · Paper page
- Neglia, 2006, JNCI Journal of the National Cancer Institute, 98, 1528, 10.1093/jnci/djj411 · DOI · Paper page
- 2010, Journal of Clinical Oncology, 28, 5287, 10.1200/JCO.2009.27.0090 · DOI
- Davis, 2011, Radiation research, 175, 790, 10.1667/RR2186.1 · DOI
- Preston-Martin, 1989, Cancer Research, 49, 6137
- 2012, CA: A Cancer Journal for Clinicians, 62, 75, 10.3322/caac.21132 · DOI · Paper page
- Pearce, 2012, Lancet, 380, 499, 10.1016/S0140-6736(12)60815-0 · DOI · Paper page
- Picano, 2012, BMC cancer [electronic resource], 12, 157, 10.1186/1471-2407-12-157 · DOI
- Baan, 2011, The lancet oncology, 12, 624, 10.1016/S1470-2045(11)70147-4 · DOI · Paper page
- 2011, BMJ, 343, d6387, 10.1136/bmj.d6387 · DOI
- 2013, International Journal of Epidemiology, 42, 792, 10.1093/ije/dyt072 · DOI
- 2013, International journal of oncology, 43, 1833, 10.3892/ijo.2013.2111 · DOI
- 2014, International Journal of Epidemiology, 43, 275, 10.1093/ije/dyt186 · DOI
- 1987, JNCI Journal of the National Cancer Institute, 78, 253, 10.1093/jnci/78.2.253 · DOI
- T rnqvist, 1991, British Journal of Industrial Medicine, 48, 597
- Tynes, 1992, American Journal of Epidemiology, 136, 81, 10.1093/oxfordjournals.aje.a116423 · DOI
- Hakansson, 2002, Occupational and Environmental Medicine, 59, 481, 10.1136/oem.59.7.481 · DOI
- 2007, Occupational and Environmental Medicine, 64, 782, 10.1136/oem.2006.029116 · DOI
- 2007, Occupational and Environmental Medicine, 64, 553, 10.1136/oem.2006.030270 · DOI
- Floderus, 1993, Cancer causes & control : CCC, 4, 465, 10.1007/BF00050866 · DOI
- Karipidis, 2007, Cancer causes & control : CCC, 18, 305, 10.1007/s10552-006-0106-7 · DOI
- 2007, Occupational Medicine, 57, 518, 10.1093/occmed/kqm078 · DOI
- Villeneuve, 2002, International Journal of Epidemiology, 31, 210, 10.1093/ije/31.1.210 · DOI
- Kheifets, 2008, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 50, 677, 10.1097/JOM.0b013e3181757a27 · DOI
- 2014, Cancer causes & control : CCC, 25, 203, 10.1007/s10552-013-0322-x · DOI
- 2009, Neuro-Oncology, 11, 242, 10.1215/15228517-2009-002 · DOI
- Baldi, 2011, International journal of cancer. Journal international du cancer, 129, 1477, 10.1002/ijc.25765 · DOI
- Feychting, 1997, Epidemiology (Cambridge, Mass.), 8, 384, 10.1097/00001648-199707000-00006 · DOI
- Savitz, 2000, American journal of industrial medicine, 38, 417, 10.1002/1097-0274(200010)38:4<417::AID-AJIM7>3.0.CO;2-W · DOI
- Sorahan, 2001, Occupational and Environmental Medicine, 58, 626, 10.1136/oem.58.10.626 · DOI
- Theriault, 1994, American Journal of Epidemiology, 139, 550, 10.1093/oxfordjournals.aje.a117046 · DOI
- Navas-Acien, 2002, Cancer Epidemiology Biomarkers & Prevention, 11, 1678
- Ohgaki, 2009, Methods in molecular biology (Clifton, N.J.), 472, 323, 10.1007/978-1-60327-492-0_14 · DOI · Paper page
- Pukkala, 2009, Acta oncologica (Stockholm, Sweden), 48, 646, 10.1080/02841860902913546 · DOI · Paper page
- Zheng, 2001, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 43, 317, 10.1097/00043764-200104000-00005 · DOI
- De Roos, 2003, Cancer causes & control : CCC, 14, 139, 10.1023/A:1023053916689 · DOI
- Khuder, 1998, American journal of industrial medicine, 34, 252, 10.1002/(SICI)1097-0274(199809)34:3<252::AID-AJIM7>3.0.CO;2-X · DOI
- Ruder, 2012, American journal of industrial medicine, 55, 747, 10.1002/ajim.22085 · DOI
- Pan, 2005, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 47, 704, 10.1097/01.jom.0000165747.95801.c5 · DOI
- 2008, American Journal of Epidemiology, 167, 976, 10.1093/aje/kwm401 · DOI
- Bucchi, 2004, Journal of occupational and environmental medicine / American College of Occupational and Environmental Medicine, 46, 249, 10.1097/01.jom.0000116804.10496.fc · DOI
- M n goz, 2002, European journal of cancer (Oxford, England : 1990), 38, 696, 10.1016/S0959-8049(01)00423-3 · DOI
- Viel, 1998, Archives of Environmental Health, 53, 65, 10.1080/00039899809605690 · DOI
- 2007, Occupational and Environmental Medicine, 64, 509, 10.1136/oem.2006.028100 · DOI
- 2013, Occupational and Environmental Medicine, 70, 73, 10.1136/oemed-2011-100588 · DOI
- Arora, 2010, European journal of cancer (Oxford, England : 1990), 46, 1607, 10.1016/j.ejca.2010.02.007 · DOI
- Arrigo, 2012, Journal of neuro-oncology, 106, 627, 10.1007/s11060-011-0702-6 · DOI
- 2010, American Journal of Epidemiology, 171, 1165, 10.1093/aje/kwq075 · DOI
- Carre n, 2005, Environmental Health Perspectives, 113, 546, 10.1289/ehp.7456 · DOI
- Yiin, 2012, Environmental health : a global access science source [electronic resource], 11, 39, 10.1186/1476-069X-11-39 · DOI
Cited by
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927
Ostrom, Q. T., Patil, N., Cioffi, G., Waite, K., Kruchko, C., & Barnholtz-Sloan, J. S. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa200 · Cited by 1,789
Self-citationOstrom, Q. T., Price, M., Neff, C., Cioffi, G., Waite, K. A., Kruchko, C., & Barnholtz-Sloan, J. S. (2023) · Neuro-Oncology · doi:10.1093/neuonc/noad149 · Cited by 1,294
Self-citationHenrik Heiland, D., Ravi, V. M., Behringer, S. P., Frenking, J. H., Wurm, J., Joseph, K., Garrelfs, N. W. C., Strähle, J., Heynckes, S., Grauvogel, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10493-6 · Cited by 437
The application of Ferroptosis in diseases
Qiu, Y., Cao, Y., Cao, W., Jia, Y., & Lu, N. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104919 · Cited by 415
Metadata
- Authors
- Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., Wrensch, M. R., & Barnholtz-Sloan, J. S.
- Venue
- Neuro-Oncology
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-05-19
- Volume
- 16
- Issue
- 7
- Pages
- 896-913
- ISSN
- 1522-8517 (ISSN-L)
- 1523-5866
- OpenAlex
- W2135465849
- Cited by
- 2,220
- References
- 7
- FWCI
- 42.91
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The epidemiology of glioma in adults: a "state of the science" review. https://app.cochat.ai/papers/10.1093/neuonc/nou087
- The paper
- Ostrom, Q. T., Bauchet, L., Davis, F. G., Deltour, I., Fisher, J. L., Langer, C. E., Pekmezci, M., Schwartzbaum, J. A., Turner, M. C., Walsh, K. M., Wrensch, M. R., & Barnholtz-Sloan, J. S. (2014). The epidemiology of glioma in adults: a "state of the science" review. Neuro-Oncology. https://doi.org/10.1093/neuonc/nou087
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.